Cryogenic OGS Limited Reports No Deviation in IPO Fund Utilization for FY26

1 min read     Updated on 30 Apr 2026, 03:23 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Cryogenic OGS Limited has filed its mandatory fund utilization statement for the half-year ended March 31, 2026, confirming no deviations in the use of ₹17.76 crores raised through its IPO on July 10, 2025. The company has systematically deployed funds across working capital requirements (₹240.12 lakhs utilized from ₹1150.00 lakhs allocated), general corporate purposes (₹284.31 lakhs from ₹396.47 lakhs), and issue expenses (₹228.29 lakhs from ₹230.13 lakhs). The statement, approved by the board and audit committee on April 30, 2026, demonstrates compliance with SEBI regulations and transparent fund management practices.

powered bylight_fuzz_icon
39088434

*this image is generated using AI for illustrative purposes only.

Cryogenic OGS Limited has submitted its compliance statement to BSE Limited regarding the utilization of funds raised through its initial public offering, confirming no deviations from the approved allocation for the half-year ended March 31, 2026. The statement, filed under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was reviewed and approved by the company's audit committee and board of directors on April 30, 2026.

IPO Fund Details and Allocation

The company raised ₹17.76 crores through its initial public offer completed on July 10, 2025. The funds were allocated across three specific objectives as outlined in the original prospectus.

Parameter Details
Mode of Fund Raising Initial Public Offer
Date of Fund Raising July 10, 2025
Total Amount Raised ₹17.76 Crores
Reporting Period Half-year ended March 31, 2026
Deviation Status No

Fund Utilization Breakdown

The detailed utilization of IPO proceeds shows systematic deployment across the three approved categories. The company has utilized funds progressively towards its stated objectives without any modifications to the original allocation.

Object of Issue Original Allocation (₹ Lakhs) Funds Utilized (₹ Lakhs) Status
Working Capital Requirements 1150.00 240.12 On Track
General Corporate Purpose 396.47 284.31 On Track
Issue Related Expenses 230.13 228.29 Nearly Complete

Compliance and Oversight

The fund utilization statement confirms that no monitoring agency oversight is required for this fundraising. Both the audit committee and external auditors have provided no adverse comments on the fund deployment strategy. The company has maintained transparency by making the statement available on its official website at cryogenicogs.com.

Corporate Governance

The statement was signed by Managing Director Nilesh Patel (DIN: 01368574) and Company Secretary & Compliance Officer Rashmi Kamlesh Otavani, demonstrating proper corporate governance protocols. The document confirms that no shareholder approval was required for any changes in fund utilization as no deviations occurred from the original objects of the issue.

Historical Stock Returns for Cryogenic Ogs

1 Day5 Days1 Month6 Months1 Year5 Years
-8.18%+30.29%+41.22%+1.56%+143.17%+143.17%

What specific business expansion plans does Cryogenic OGS have for the remaining ₹910 lakhs in working capital funds over the next reporting periods?

How will the company's financial performance in FY2027 be impacted by the strategic deployment of these IPO proceeds?

What market opportunities in the cryogenic equipment sector is Cryogenic OGS positioning itself to capture with this capital infusion?

Cryogenic OGS FY26 net profit rises 67% to ₹1018.27 lakh, revenue up 24%

2 min read     Updated on 30 Apr 2026, 03:09 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Cryogenic OGS Limited delivered impressive FY26 performance with net profit surging 67% to ₹1018.27 lakh and total revenue increasing 24% to ₹4243.48 lakh. The company's balance sheet strengthened significantly with shareholders' funds growing to ₹5465.18 lakh and cash reserves reaching ₹3278.24 lakh.

powered bylight_fuzz_icon
38746478

*this image is generated using AI for illustrative purposes only.

Cryogenic OGS Limited has reported its audited financial results for FY26, with the Board of Directors approving the results at a meeting held on 30 April 2026. The company, engaged in manufacturing equipment for oil and gas industries, posted strong growth across key financial metrics compared to the previous year.

Financial Performance Summary

The company achieved total revenue of ₹4243.48 lakh for FY26, representing a 24% increase from ₹3379.14 lakh in the previous year. Revenue from operations stood at ₹4082.24 lakh, while other income contributed ₹161.24 lakh. For the half-year ended 31 March 2026, total revenue reached ₹2072.22 lakh.

Particulars: Year ended 31/03/2026 Year ended 31/03/2025 Half Year ended 31/03/2026
Total Revenue: ₹4243.48 lakh ₹3379.14 lakh ₹2072.22 lakh
Total Expenses: ₹3018.25 lakh ₹2552.36 lakh ₹1451.01 lakh
Profit before Tax: ₹1349.18 lakh ₹826.79 lakh ₹621.22 lakh
Profit after Tax: ₹1018.27 lakh ₹608.98 lakh ₹447.22 lakh
Basic EPS: ₹7.69 ₹5.80 ₹3.17

Profitability Analysis

Profit after tax for FY26 increased to ₹1018.27 lakh, up 67% from ₹608.98 lakh in FY25. The company reported an exceptional item of ₹123.95 lakh as profit on sale of plot during the year. Basic and diluted earnings per share improved to ₹7.69 from ₹5.80 in the previous year. For the half-year period, profit after tax stood at ₹447.22 lakh with EPS of ₹3.17.

Balance Sheet Position

The company's balance sheet strengthened significantly with shareholders' funds growing to ₹5465.18 lakh as of 31 March 2026, compared to ₹2898.60 lakh in the previous year. Share capital increased to ₹1428.00 lakh from ₹1050.00 lakh, while reserves and surplus rose to ₹4037.18 lakh from ₹1848.60 lakh. Cash and cash equivalents surged to ₹3278.24 lakh from ₹1106.67 lakh, reflecting strong liquidity position.

Parameter: As at 31st March 2026 As at 31st March 2025
Shareholders' Funds: ₹5465.18 lakh ₹2898.60 lakh
Share Capital: ₹1428.00 lakh ₹1050.00 lakh
Cash & Cash Equivalents: ₹3278.24 lakh ₹1106.67 lakh
Total Assets: ₹6671.75 lakh ₹3385.41 lakh

Cash Flow and Financing

Net cash from operating activities improved to ₹798.59 lakh in FY26 from ₹193.55 lakh in the previous year. The company raised ₹1548.31 lakh through issue of shares during the year. Cash flow from investment activities showed an outflow of ₹2056.49 lakh, primarily due to investments in fixed deposits of ₹1892.37 lakh. Closing cash and cash equivalents as per financials stood at ₹3278.24 lakh.

Auditor's Report

M/s Maloo Bhatt & Co., Chartered Accountants, provided an unmodified opinion on the audited financial results. The audit report confirmed that the financial results are presented in accordance with Regulation 33 of SEBI Listing Regulations and give a true and fair view of the company's financial performance for FY26.

Historical Stock Returns for Cryogenic Ogs

1 Day5 Days1 Month6 Months1 Year5 Years
-8.18%+30.29%+41.22%+1.56%+143.17%+143.17%

How will the recent capital raise of ₹1548.31 lakh be deployed to sustain the company's 24% revenue growth trajectory in FY27?

What impact could the current oil and gas industry consolidation trends have on Cryogenic OGS's order book and pricing power?

Will the company's substantial cash position of ₹3278.24 lakh trigger any strategic acquisitions or capacity expansion plans?

More News on Cryogenic Ogs

1 Year Returns:+143.17%